title: Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer.
authors.affiliation: Finsen Laboratory, Copenhagen ø, Denmark.
authors.forename: N
authors.initials: N
authors.lastname: Brünner
authors.forename: C
authors.initials: C
authors.lastname: Pyke
authors.forename: C H
authors.initials: CH
authors.lastname: Hansen
authors.forename: J
authors.initials: J
authors.lastname: Rømer
authors.forename: J
authors.initials: J
authors.lastname: Grøndahl-Hansen
authors.forename: K
authors.initials: K
authors.lastname: Danø
mesh_terms: D001943:Breast Neoplasms / Q000201:enzymology / Q000473:pathology / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008666:Metalloendopeptidases / Q000502:physiology*; D009361:Neoplasm Invasiveness; D017395:Plasminogen Activator Inhibitor 1 / Q000502:physiology*; D011379:Prognosis; D012697:Serine Endopeptidases / Q000502:physiology*; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors / Q000502:physiology*
chemical_list: D017395:Plasminogen Activator Inhibitor 1; D012697:Serine Endopeptidases; D014568:Urokinase-Type Plasminogen Activator; D008666:Metalloendopeptidases